How do GLP-1 medications compare to other weight loss drugs?

What GLP-1 medications are GLP-1 receptor agonists (GLP-1 RAs) are drugs that mimic a natural hormone to help control appetite, blood sugar, and weight. They were first approved for type 2 diabetes and later at higher doses for obesity and for adults with overweight and weight-related conditions. Examples include semaglutide and tirzepatide, which are typically given as once-weekly injections, with some oral options emerging.

What other weight loss drugs are Older long-term weight-loss medications include combinations such as phentermine–topiramate, bupropion–naltrexone, and orlistat. These drugs usually work by suppressing appetite, affecting reward pathways, or reducing fat absorption, and they are generally taken by mouth. They can help some people lose weight, but on average they lead to smaller weight changes than GLP-1–based therapies in clinical trials.

How much weight people typically lose In major trials, GLP-1–based treatments at obesity doses often produce average weight losses in the 10–15 percent range, with some newer multi-receptor drugs approaching or exceeding 20 percent in selected studies. By comparison, older medications like phentermine–topiramate, bupropion–naltrexone, and orlistat have typically shown average losses of a few percent up to the high single digits of body weight. Individual results vary widely, and no medication guarantees a specific amount of weight loss.

How they are taken Many GLP-1 medications for weight loss are given as once-weekly injections, though some oral versions exist or are in development. Most older weight-loss drugs are taken by mouth one or more times a day. Route and schedule matter because GLP-1 treatments are often used long term; some people prefer injections once a week, while others prefer pills.

Side effects and safety GLP-1 therapies commonly cause gastrointestinal side effects such as nausea, vomiting, and diarrhea, especially when treatment is started or doses are increased. Serious complications appear uncommon in trials but are monitored and discussed as part of prescribing decisions. Older medications have their own side-effect profiles, which may include changes in heart rate or blood pressure, mood effects, or digestive issues, depending on the drug. Because risks and benefits differ, clinicians usually review health history, other medications, and monitoring needs before recommending any option.

Cost and access GLP-1 medications are often more expensive than older weight-loss drugs, and insurance coverage varies by plan, diagnosis, and region. Older oral medications may cost less but generally do not provide the same average weight loss or cardiometabolic benefits seen with newer GLP-1–based therapies. Coverage rules, prior authorizations, and assistance programs can all affect which medications are realistically available to a given person.

Who might consider each option GLP-1–based treatments are often considered for adults with obesity or overweight plus weight-related conditions who meet eligibility criteria, can tolerate injections, and have a way to afford ongoing treatment. Older medications may be reasonable for people who cannot use GLP-1 drugs, prefer oral treatments, or need lower-cost options after discussing trade-offs with a clinician. Decisions about any weight-loss medication should be made with a clinician who can weigh health history, other medications, preferences, and long-term goals.

Action steps - Make a list of your health conditions, current medications, and past experiences with weight-loss efforts. - Ask a clinician whether weight-loss medications are appropriate for you and, if so, which options fit your health profile. - Compare not only expected weight loss but also side effects, monitoring, route of administration, and total cost over time. - Review what might happen if you stop treatment and how to maintain weight changes.

Risks and limitations Trial results represent averages; individual responses can be higher or lower than reported numbers. Long-term benefits and risks are still being studied, especially for newer drugs and combination therapies. Some medications may not be safe for people with certain conditions or in combination with particular drugs. Information about coverage and costs can change quickly and should be rechecked with insurers and pharmacies.